ESSA Pharma Stock (NASDAQ:EPIX)
Previous Close
$1.77
52W Range
$1.40 - $7.88
50D Avg
$1.63
200D Avg
$3.36
Market Cap
$79.46M
Avg Vol (3M)
$180.89K
Beta
1.61
Div Yield
-
EPIX Company Profile
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.